GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
87 hedge funds and large institutions have $39M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 28
Holders
87
Holding in Top 10
–
Calls
$1.78M
Puts
$570K
Top Buyers
| 1 | +$4.81M | |
| 2 | +$1.45M | |
| 3 | +$1.29M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.04M |
| 5 |
Morgan Stanley
New York
|
+$930K |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$1.34M | |
| 3 | -$1.1M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$794K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$477K |